AUTHOR=Niami Fatemeh , Molavynejad Shahram , Hemmati Ali Asghar , Bijan Nejad Darioush , Yazdanpanah Leila , Maram Nader Shakiba , Saki Malehi Amal , Mahmoudi Mandana 

TITLE=Evaluation of the effect of a gel made with amniotic fluid formulation on the healing of diabetic foot ulcers: A triple-blind clinical trial

JOURNAL=Frontiers in Public Health

VOLUME=10

YEAR=2022

URL=https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.1025391

DOI=10.3389/fpubh.2022.1025391

ISSN=2296-2565

ABSTRACT=<sec><title>Aim</title><p>The aim of this study was to evaluate the effect of a gel made with amniotic fluid (AF) formulation on wound healing in diabetic foot ulcers.</p></sec><sec><title>Methods</title><p>This clinical trial was performed on 92 type 2 diabetic patients referring to the Diabetes Clinic of Golestan Hospital of Ahvaz, southwest of Iran in 2019–2020. Patients were randomly divided into three groups of intervention and one placebo group. The wounds of the three intervention groups were dressed with gauze impregnated with an AF formulation gel while wounds of the control group were dressed with plain gauze without any topical agent. Chi-square tests and generalized estimating equations (GEE) with a significance level of 0.05 were used to analyze the data.</p></sec><sec><title>Results</title><p>At the end of the eighth week of intervention, there was a statistically significant difference among the four groups in terms of wound grade, wound color, condition of the tissues surrounding the wound, the overall condition of the wound, and the duration of wound healing (<italic>P</italic> &lt; 0.05).</p></sec><sec><title>Conclusions</title><p>Based on our experience with the patients in the present study, we believe that AF represents a useful and safe option for the treatment of chronic diabetic foot ulcers.</p></sec><sec><title>Clinical trial registration</title><p><ext-link ext-link-type="uri" xlink:href="https://en.irct.ir/trial/51551" xmlns:xlink="http://www.w3.org/1999/xlink">https://en.irct.ir/trial/51551</ext-link>, Identifier: IRCT20201010048985N1.</p></sec>